ImmuCell Corporation Income Taxes Paid
ImmuCell Corporation (ICCC) reported Income Taxes Paid of $10.61 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-08-13
- ImmuCell Corporation income taxes paid, net for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- ImmuCell Corporation income taxes paid, net for the quarter ending 2026-03-31 was $10.61K.
- ImmuCell Corporation income taxes paid, net for the quarter ending 2025-12-31 was $486.00, a 64.99% decline year-over-year.
- ImmuCell Corporation income taxes paid, net for the quarter ending 2025-09-30 was $0.00.
- ImmuCell Corporation income taxes paid, net for fiscal 2025 was $10.69K, a 46.59% increase from fiscal 2024.
- ImmuCell Corporation income taxes paid, net for fiscal 2024 was $7.29K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.61K 10-Q · filed 2026-08-13 | $11.10K derived: sum of 3 quarters · filed 2026-08-13 | $11.10K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $10.61K 10-Q · filed 2026-05-14 | $11.10K derived: sum of 2 quarters · filed 2026-05-14 | $11.10K derived: sum of 3 quarters · filed 2026-05-14 | $21.30K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $486.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $486.00 derived: sum of 2 quarters · filed 2026-03-30 | $10.69K derived: sum of 3 quarters · filed 2026-08-13 | $10.69K 10-K · filed 2026-03-30 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $10.21K derived: sum of 2 quarters · filed 2026-08-13 | $10.21K 10-Q · filed 2025-11-13 | $11.59K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $10.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.21K 10-Q · filed 2026-08-13 | $11.59K derived: sum of 3 quarters · filed 2026-08-13 | $11.59K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-14 | $1.39K derived: sum of 2 quarters · filed 2026-05-14 | $1.39K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | $1.39K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $1.39K derived: sum of 2 quarters · filed 2026-03-30 | $7.29K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $5.91K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | $5.91K 10-Q · filed 2025-08-14 | |||
| 2023-06-30 | $88.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $176.45K 10-Q · filed 2023-08-10 | ||
| 2023-03-31 | $88.04K 10-Q · filed 2023-05-11 | |||
| 2022-06-30 | $87.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $159.40K 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $71.88K 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |